A validated LC-MS/MS method for the low-level determination of pemafibrate, a novel SPPARMα, in plasma.

2020 
Background: Pemafibrate, a novel selective peroxisome proliferator-activated receptor-α modulator, is prescribed for patients with dyslipidemia. To investigate other potential nonlipid-related effe...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    10
    References
    0
    Citations
    NaN
    KQI
    []